| The burden of gastrointestinal and liver diseases, 2006 NJ Shaheen, RA Hansen, DR Morgan, LM Gangarosa, Y Ringel, ... Official journal of the American College of Gastroenterology| ACG 101 (9 …, 2006 | 799 | 2006 |
| Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis RA Hansen, G Gartlehner, AP Webb, LC Morgan, CG Moore, DE Jonas Clinical interventions in aging 3 (2), 211-225, 2008 | 742 | 2008 |
| Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis G Gartlehner, RA Hansen, LC Morgan, K Thaler, L Lux, M Van Noord, ... Annals of internal medicine 155 (11), 772-785, 2011 | 485 | 2011 |
| Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis KE Donahue, G Gartlehner, DE Jonas, LJ Lux, P Thieda, BL Jonas, ... Annals of internal medicine 148 (2), 124-134, 2008 | 483 | 2008 |
| Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis BN Gaynes, SW Lloyd, L Lux, G Gartlehner, RA Hansen, S Brode, ... The Journal of clinical psychiatry 75 (5), 29758, 2014 | 392 | 2014 |
| Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder RA Hansen, G Gartlehner, KN Lohr, BN Gaynes, TS Carey Annals of Internal Medicine 143 (6), 415-426, 2005 | 387 | 2005 |
| Adherence: comparison of methods to assess medication adherence and classify nonadherence RA Hansen, MM Kim, L Song, W Tu, J Wu, MD Murray Annals of Pharmacotherapy 43 (3), 413-422, 2009 | 340 | 2009 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 338 | 2001 |
| The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. G Gartlehner, RA Hansen, BL Jonas, P Thieda, KN Lohr The Journal of Rheumatology 33 (12), 2398-2408, 2006 | 336 | 2006 |
| Criteria for distinguishing effectiveness from efficacy trials in systematic reviews G Gartlehner, RA Hansen, D Nissman, KN Lohr, TS Carey | 314 | 2010 |
| Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians G Gartlehner, BN Gaynes, RA Hansen, P Thieda, A DeVeaugh-Geiss, ... Annals of internal medicine 149 (10), 734-750, 2008 | 304 | 2008 |
| A simple and valid tool distinguished efficacy from effectiveness studies G Gartlehner, RA Hansen, D Nissman, KN Lohr, TS Carey Journal of clinical epidemiology 59 (10), 1040-1048, 2006 | 271 | 2006 |
| Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes G Gartlehner, RA Hansen, SS Carson, KN Lohr The Annals of Family Medicine 4 (3), 253-262, 2006 | 230 | 2006 |
| Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry A Kaifie, M Kirschner, D Wolf, C Maintz, M Hänel, N Gattermann, ... Journal of hematology & oncology 9, 1-11, 2016 | 204 | 2016 |
| Comparative Risk for Harms of Second Generation Antidepressants: A Systematic Review and Meta Analysis G Gartlehner, P Thieda, RA Hansen, BN Gaynes, A DeVeaugh-Geiss, ... Drug Safety 31, 851-865, 2008 | 176 | 2008 |
| Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis U Reichenpfader, G Gartlehner, LC Morgan, A Greenblatt, B Nussbaumer, ... Drug safety 37, 19-31, 2014 | 164 | 2014 |
| Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants R Hansen, B Gaynes, P Thieda, G Gartlehner, A Deveaugh-Geiss, ... Psychiatric services 59 (10), 1121-1130, 2008 | 163 | 2008 |
| Medication adherence in chronic disease: issues in posttransplant immunosuppression R Hansen, R Seifeldin, L Noe Transplantation proceedings 39 (5), 1287-1300, 2007 | 162 | 2007 |
| Empirical estimation of under-reporting in the US Food and Drug Administration adverse event reporting system (FAERS) YM Alatawi, RA Hansen Expert opinion on drug safety 16 (7), 761-767, 2017 | 142 | 2017 |
| Preventing medication errors in long-term care: results and evaluation of a large scale web-based error reporting system S Pierson, R Hansen, S Greene, C Williams, R Akers, M Jonsson, T Carey BMJ Quality & Safety 16 (4), 297-302, 2007 | 139 | 2007 |
Jingjing QianAuburn UniversityDirección de correo verificada de auburn.edu
